Effective Interventions and Decline of Antituberculosis Drug Resistance in Eastern Taiwan, 2004–2008
by Yi-Ting Chen, Jen-Jyh Lee, Chen-Yuan Chiang, Gee-Gow Yang, Yeong-Chu Tsai, Yeong-Sheng Lee, Chih-Bin Lin
The Taiwan health authority recently launched several tuberculosis (TB) control interventions, which may have an impact on the epidemic of drug-resistant TB. We conducted a population-based antituberculosis drug resistance surveillance program in Eastern Taiwan to measure the proportions of notified TB patients with anti-TB drug resistance and the trend from 2004 to 2008.
Methods and Findings
All culture-positive TB patients were enrolled. Drug susceptibility testing results of the first isolate of each TB patient in each treatment course were analyzed. In total, 2688 patients were included, of which 2176 (81.0%) were new TB cases and 512 (19.0%) were previously treated cases. Among the 2176 new TB cases, 97 (4.5%) were retreated after the first episode of TB treatment within the study period. The proportion of new patients with any resistance, isoniazid resistance but not multidrug-resistant TB (resistant to at least isoniazid and rifampin, MDR-TB), and MDR-TB was 16.4%, 7.5%, and 4.0%, respectively, and that among previously treated cases was 30.9%, 7.9%, and 17.6%, respectively. The combined proportion of any resistance decreased from 23.3% in 2004 to 14.3% in 2008, and that of MDR-TB from 11.5% to 2.4%.
The proportion of TB patients with drug-resistant TB in Eastern Taiwan remains substantial. However, an effective TB control program has successfully driven the proportion of drug resistance among TB patients downward.
For the full article visit: Effective Interventions and Decline of Antituberculosis Drug Resistance in Eastern Taiwan, 2004–2008
Syndicated from:PLoS ONE
Article is licensed under a Creative Commons Attribution License.